title: Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.
authors.forename: A
authors.initials: A
authors.lastname: Abad
authors.forename: B
authors.initials: B
authors.lastname: Masuti
authors.forename: C
authors.initials: C
authors.lastname: Camps
authors.forename: A
authors.initials: A
authors.lastname: Font
authors.forename: C
authors.initials: C
authors.lastname: Balañá
authors.forename: J M
authors.initials: JM
authors.lastname: Vicent
authors.forename: J J
authors.initials: JJ
authors.lastname: Sánchez
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D014268:Trifluoperazine / Q000008:administration & dosage
chemical_list: D014268:Trifluoperazine; D015251:Epirubicin